Dosimetric implications of the potential radionuclidic impurities in 153Sm-DOTMP

Authors

Richard E. Wendt PHD, The University of MD Anderson Cancer Center
Alan R. Ketring PhD, IsoTherapeutics Group, LLC
R Keith Frank PhD, IsoTherapeutics Group, LLC
Jaime Simon PhD, IsoTherapeutics Group, LLC

Files

DOI

https://doi.org/10.1016/j.apradiso.2022.110246

Publication Date

4-14-2022

Publisher

Elsevier

Keywords

Internal dosimetry, Radionuclidic impurities

Recommended Citation

Wendt, Richard E. PHD; Ketring, Alan R. PhD; Frank, R Keith PhD; and Simon, Jaime PhD, "Dosimetric implications of the potential radionuclidic impurities in 153Sm-DOTMP" (2022). Articles. 1.
doi:https://doi.org/10.1016/j.apradiso.2022.110246

Journal Citation

Wendt RE, Ketring AR, Frank RK, Simón J. Dosimetric implications of the potential radionuclidic impurities in 153Sm-DOTMP. Applied radiation and isotopes. Elsevier Ltd; 2022;185:110246–110246.